Occudo Quantitative Strategies’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.5K Buy
+12,141
New +$73.3K ﹤0.01% 741
2024
Q3
Sell
-6,616
Closed -$398K 990
2024
Q2
$398K Sell
6,616
-3,203
-33% -$183K 0.07% 361
2024
Q1
$506K Sell
9,819
-21,609
-69% -$1.06M 0.09% 301
2023
Q4
$1.27M Buy
+31,428
New +$922K 0.17% 163
2023
Q3
Sell
-17,544
Closed -$505K 1273
2023
Q2
$505K Buy
+17,544
New +$390K 0.05% 555

Other funds holding RXST

Occudo Quantitative Strategies's RXST Position: Q2 2026 in Review

Occudo Quantitative Strategies opened a new position in RxSight (RXST) in Q2 2026: 12,141 shares worth $58.5K. The stake represents ﹤0.01% of the portfolio and ranks #741 among its holdings. This is a return to the name: Occudo Quantitative Strategies previously reported a position in RXST as recently as Q2 2024.

Occudo Quantitative Strategies first reported a position in RXST in Q2 2023 and has held it in 5 quarters since. The position peaked at $1.27M in Q4 2023. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

  • Occudo Quantitative Strategies held 12,141 shares of RxSight worth $58.5K as of Q2 2026.
  • RxSight was a new Occudo Quantitative Strategies position in Q2 2026.
  • RxSight made up ﹤0.01% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #741 holding.
  • Occudo Quantitative Strategies first reported a position in RxSight in Q2 2023 and has held it in 5 quarters since.
  • Occudo Quantitative Strategies's RxSight position peaked at $1.27M in Q4 2023.
  • 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.